Intravenous thrombolysis after reversal of dabigatran by idarucizumab: a moment to be a pioneer
Crossref DOI link: https://doi.org/10.1007/s13760-017-0751-5
Published Online: 2017-01-30
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Turine, G.
Peeters, A. http://orcid.org/0000-0001-9989-4283
Hermans, C.
Eeckhoudt, S.
Duprez, T.
License valid from 2017-01-30